Olympus Corporation (TYO:7733)

Market Cap	2.24T +12.0%
Revenue (ttm)	1.04T +7.8%
Net Income	78.28B -30.3%
EPS	71.10 -28.0%
Shares Out	1.06B
PE Ratio	29.68
Forward PE	21.30
Dividend	30.00 (1.45%)
Ex-Dividend Date	Mar 30, 2026

Volume	5,691,400
Open	2,080.50
Previous Close	2,067.50
Day's Range	2,047.00 - 2,119.50
52-Week Range	1,302.50 - 2,168.00
Beta	0.21
Analysts	Hold
Price Target	2,011.54 (-4.69%)
Earnings Date	Aug 7, 2026

About Olympus

Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, “Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology product...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1919
• Employees: 28,138
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7733

Financial Performance

In fiscal year 2026, Olympus's revenue was 1.01 trillion, an increase of 1.34% compared to the previous year's 997.33 billion. Earnings were 68.17 billion, a decrease of -42.16%.

Analyst Summary

According to 14 analysts, the average rating for 7733 stock is "Hold." The 12-month stock price target is ¥2,012, which is a decrease of -4.69% from the latest price.

Price Target

¥2,012

(-4.69% downside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 14, 2026

Data Sources Report a data error